In the surveillance phase, the safety of a drug or device is monitored through various approaches.
From big data to smart knowledge
The term big data seems old school now that ‘machine learning’, ‘deep learning’ and emerging concepts such as ‘edge AI’ are the hypes of the day. However, despite our general familiarity with the concept of big data, challenges related to data-driven decision-making still remain. Several key learnings about data have emerged over the last decade, and the tension between the culture of generating massive volumes of data and the culture of applying that data to achieve meaningful outcomes is now stronger than ever. How do we use our expensive data processing and analytics tools to generate actionable insights? Learn more in this whitepaper.